U.S. medical researchers have determined the anti-inflammatory drug celecoxib (Celebrex) can adversely affect heart rhythm in fruit fly and rat models.
COX-2 inhibitors such as celecoxib have come under scrutiny due to adverse cardiovascular side-effects stemming from COX-2 reduction. But the new study found the drug-induced arrhythmia is independent of the COX-2 enzyme.
Satpal Singh and colleagues at the State University of New York at Buffalo tested various celecoxib doses on the heart rate of the fruit fly Drosophila. They found celecoxib reduced heart rate and increased beating irregularities.
The finding was a surprise, the researchers said, since Drosophila do not have COX-2 enzymes. Rather, the scientists said, celecoxib might directly inhibit the potassium channels that help generate the electric current that drives heartbeat.
Singh and colleagues note that since the arrhythmia effects bypass COX-2, it is unclear if other COX-2 inhibitors would yield similar results. They also stress it is too early to speculate on human effects.
The research appears in the Journal of Biological Chemistry.
Copyright 2008 by United Press International
Related stories:
A genetic 'gang of 4' drives spread of breast cancer
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs. The new studies by Howard Hughes Medical Institute researchers reveal that the aberrant genes work together to promote the growth of primary breast tumors. Cooperation among the four genes also enables cancerous cells to escape into the bloodstream and penetrate through blood vessels into lung tissues.
Supplements no better than placebo in slowing cartilage loss in knees of osteoarthritis patients
In a two-year multicenter study led by University of Utah doctors, the dietary supplements glucosamine and chondroitin sulfate performed no better than placebo in slowing the rate of cartilage loss in the knees of osteoarthritis patients.
Anti-inflammatory drugs do not improve cognitive function in older adults
The anti-inflammatory drugs naproxen and celecoxib do not appear to improve cognitive function in older adults with a family history of Alzheimer’s disease, and naproxen may have a slightly detrimental effect, according to an article posted online today that will appear in the July 2008 print issue of
Archives of Neurology.
Ibuprofen linked to reduced risk of Alzheimer's disease
Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer’s disease, according to a study published in the May 6, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology. Previous studies have shown conflicting results, but this is the longest study of its kind.
Celebrex-Lipitor combo may halt prostate cancer
Researchers at Rutgers’ Ernest Mario School of Pharmacy have shown that administering a combination of the widely used drugs Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) and Lipitor (atorvastatin, a cholesterol lowering drug) stops the transition of early prostate cancer to its more aggressive and potentially fatal stage.
Commonly used drug offers promise for premature babies
Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
Commonly used pain medications do not prevent Alzheimer's disease
Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to a study published April 25, 2007, in the online edition of
Neurology, the scientific journal of the American Academy of Neurology. These findings appear to contradict earlier observational studies, which found sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) may have a protective effect against Alzheimer's disease.
Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.